Photodynamic therapy for psoriasis?

Australasian Journal of Dermatology

Volumn 37, Issue 2, 1996, Pages 87-88

  Fergin, Peter ^a,b  

^a SKIN AND CANCER FOUNDATION   (Australia)

^b NONE   (Australia)

Author keywords

Photodynamic therapy; Psoriasis

Indexed keywords

AMINOLEVULINIC ACID; RADIOSENSITIZING AGENT;

HUMAN; NEOPLASM; PHOTOCHEMOTHERAPY; PSORIASIS; REVIEW; SKIN TUMOR;

AMINOLEVULINIC ACID; HUMANS; NEOPLASMS; PHOTOCHEMOTHERAPY; PSORIASIS; RADIATION-SENSITIZING AGENTS; SKIN NEOPLASMS;

EID: 0030147983     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.1996.tb01011.x     Document Type: Review

References (17)

1. Robinson PJ, Carruth JAS, Fairris GM. Photodynamic therapy: a better treatment for widespread Bowen's disease. Br. J. Dermatol. 1988; 119: 59-61.
2. Warloe T, Peng Q, Moan J, Qvist HL, Giercksky K-E. Photochemotherapy of multiple basal cell carcinoma with endogenous porphyrins induced by topical application of 5-aminolevulinic acid. In: Spinelli P, Dal Fante M, Marchesani R (eds.) Photodynamic Therapy and Biomedical Lasers. Elsevier Science Publishers, Amsterdam, 1992; 449-53.
3. Wilson D, Mang T, Stoll H, Jones C, Cooper M, Dougherty TJ. Photodynamic Therapy for the treatment of basal cell carcinoma. Arch. Dermatol. 1992; 128: 1597-1601.
4. Wolf P, Rieger E, Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J. Am. Acad. Dermatol. 1993; 28: 17-21.
5. Silver H. Psoriasis vulgaris treated with hematoporphyrin. Arch. Dermatol. Syphilol. 1937; 36: 1118-19.
6. Berns MW, Rettenmaier M, McCullough J et al. Response of psoriasis to red laser light (630 nm) following systemic injection of hematoporphyrin derivative. Lasers Surg. Med. 1984; 4: 73-7.
7. Diezel WH, Meffert, Sonnichsen N. Therapie der Psoriasis mit Hamatoporphyrin und Licht. Dermatol. Monattschr. 1980; 166: 793-7
8. Pres H, Meffert H, Sonnichsen N. Photodynamic therapy of psoriasis palmaris et plantaris using a topically applied hematoporphyrin derivative and visible light. Dermatol. Monattschr. 1989; 175: 745-50.
9. Emtestam L, Berglund L, Angelin B, Drummond GS, Kappas A. Tin-protoporphyrin and long wavelength ultraviolet light in treatment of psoriasis. Lancet 1989; 1: 1231-3.
10. Weinstein GD, McCullough JL, Nelson JS, Berns MW, McCormick A. Low dose photofrin II photodynamic therapy of psoriasis. J. Invest. Dermatol. 1991; 96: 573.
11. Boehncke W-H, Sterry W, Kaufman R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 1994;
12. Musser DA, Fiel RJ. Cutaneous photosensitizing and immunosuppressive effects of a series of tumor localizing porphyrins. Photochem. Photobiol. 1991; 53: 119-23.
13. Elmets CA, Bowen KD. Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. Cancer Res. 1985; 46: 1608-11.
14. Jolies CJ, Ott MJ, Straight RC, Lynch DH. Systemic immunosuppression induced by peritoneal photodynamic therapy. Am. J. Obstet. Gynecol. 1988; 158: 1446-53.
15. Boehncke W-H, Konig K, Kaufmann R, Scheffold W, Prummer O, Sterry W. Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo. Arch. Dermatol. Res. 1994; 286: 300-3.
16. 2 from cells by photodynamic treatment in vitro. Cancer Res. 1989; 49: 6896-900.
17. Kerdel FA, Soter NA, Lim HW. In vivo mediator release and degranulation of mast cells in hematoporphyrin derivative-induced phototoxicity in mice. J. Invest. Dermatol. 1987; 88: 277-80.